Suchergebnisse - "Cubillo, Antonio"

PubPharm (11)

1

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

2

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Yoo, C. | Javle, M. | Verdaguer Mata, H. | +17

3

Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients : a Multi-center Retrospective Study

enthalten in: Journal of digital imaging | 2022

von Wu, J. | de la Hoz, M. | Kuo, P. | +15

4

Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma : Results of a retrospective multicenter study

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2021

von Bonvalot, S. | Wunder, J. | Gronchi, A. | +12

CommentIn: Eur J Surg Oncol. 2021 Aug;47(8):2207. - PMID 33895024

5

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE) : a phase 3 randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Merle, P. | Blanc, J. | Phelip, J. | +91

CommentIn: Lancet Gastroenterol Hepatol. 2019 Jun;4(6):418-420. - PMID 30954566

6

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Hubner, R. | Cubillo, A. | Blanc, J. | +10

7

Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

enthalten in: Cancer medicine | 2018

von Fogelman, D. | Cubillo, A. | García-Alfonso, P. | +12

8

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

9

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis

enthalten in: British journal of cancer | 2017

von Pelzer, U. | Blanc, J. | Melisi, D. | +11

10

Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Paz-Ares, L. | Forster, M. | Boni, V. | +9